おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Sinil Kim
Overview
- Gender
- male
Dr. Sinil Kim is the Chief Medical Officer and VP of Oncology at Mirna Therapeutics, Inc. Dr. Kim received his B.S. in Chemistry and M.D. from the University of Washington, completed his Hematology/Oncology post-doctoral fellowship at University of California San Diego and served as an Associate Professor. He co-founded DepoTech Corp to work on DepoCyt, DepoDur and Exparel, and subsequently moved to Bristol-Myers Squibb to join the Erbitux BLA filing team. Most recently, Dr. Kim served as the Global Clinical Leader for Inlyta and Torisel at Pfizer, Inc.
Jobs
Number of Current Jobs
1
Sinil Kim has 1 current jobs including
Chief Medical Officer at Mirna Therapeutics
,
.
| Organization Name | Title At Company | Start Date | End Date | |
|---|---|---|---|---|
Mirna Therapeutics
|
Chief Medical Officer | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
